Development of an orally bioavailable selective inhibitor of the menin-MLL

  • Genes Dis. 2022 Oct 18;10(5):1735-1738. doi: 10.1016/j.gendis.2022.10.005.
Hai-Jing Zhong  1  2  3 ,  Wanhe Wang  4 ,  Wei Zhou  2 ,  Jia-Xin Liang  1 ,  Yung-Chi Cheng  2 ,  Dik-Lung Ma  4 ,  Chung-Hang Leung  1  5
Affiliations
  • 1. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
  • 2. Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
  • 3. International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), College of Pharmacy, Jinan University, Guangzhou, Guangdong 510632, China.
  • 4. Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China.
  • 5. Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Macao SAR, China.
PMID: 37492738 DOI: 10.1016/j.gendis.2022.10.005
Products